ADAPTIVE BIOTECHNOLOGIES COR's ticker is and the CUSIP is 00650F909. A total of 4 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | +33.8% | 16,800 | +64.7% | 0.00% | – |
| Q2 2023 | $68 | -55.6% | 10,200 | -41.4% | 0.00% | – |
| Q1 2023 | $153 | +142.9% | 17,400 | +109.6% | 0.00% | – |
| Q4 2022 | $63 | -100.0% | 8,300 | -65.6% | 0.00% | – |
| Q3 2022 | $171,000 | -51.3% | 24,100 | -44.6% | 0.00% | – |
| Q2 2022 | $351,000 | +408.7% | 43,500 | +770.0% | 0.00% | – |
| Q1 2022 | $69,000 | +91.7% | 5,000 | +284.6% | 0.00% | – |
| Q4 2021 | $36,000 | -95.6% | 1,300 | -93.7% | 0.00% | -100.0% |
| Q3 2021 | $821,000 | -3.3% | 20,600 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $849,000 | +252.3% | 20,800 | +34566.7% | 0.00% | – |
| Q1 2021 | $241,000 | -79.4% | 60 | -69.7% | 0.00% | -100.0% |
| Q4 2020 | $1,170,000 | -34.8% | 198 | -46.3% | 0.00% | 0.0% |
| Q3 2020 | $1,794,000 | -3.9% | 369 | -4.4% | 0.00% | -33.3% |
| Q2 2020 | $1,867,000 | +548.3% | 386 | +271.2% | 0.00% | +200.0% |
| Q1 2020 | $288,000 | +1957.1% | 104 | +1980.0% | 0.00% | – |
| Q4 2019 | $14,000 | -99.2% | 5 | -99.1% | 0.00% | -100.0% |
| Q3 2019 | $1,668,000 | – | 540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 750,000 | $5,730,000 | 0.30% |
| GROUP ONE TRADING, L.P. | 100 | $764 | 0.00% |
| SIMPLEX TRADING, LLC | 8,300 | $63 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |